Soluble Human Complement Receptor Type 1: In Vivo Inhibitor of Complement Suppressing Post-Ischemic Myocardial Inflammation and NecrosisHarlan F. Weisman, Douglas T. Fearon, Michelle K. Leppo et al.|Science|1990Cited by 979
Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac ArrestPeter J. Kudenchuk, Paul Dorian, James Christenson et al.|New England Journal of Medicine|2016Cited by 458
Standardized Definitions for Cardiogenic Shock Research and Mechanical Circulatory Support Devices: Scientific Expert Panel From the Shock Academic Research Consortium (SHARC)Ron Waksman, William T. Abraham, Mohit Pahuja et al.|Circulation|2023Cited by 174
The Public Access Defibrillation (PAD) TrialJoseph P. Ornato, Mohamud Daya, Mary Ann McBurnie et al.|Resuscitation|2003Cited by 98
Variation in Survival After Out-of-Hospital Cardiac Arrest Between Emergency Medical Services AgenciesMasashi Okubo, Clifton W. Callaway, Robert H. Schmicker et al.|JAMA Cardiology|2018Cited by 74